Welcome to our dedicated page for Ibex news (Ticker: IBEX), a resource for investors and traders seeking the latest updates and insights on Ibex stock.
IBEX Ltd (IBEX) is a global leader in business process outsourcing and AI-powered customer engagement solutions, serving enterprises across telecommunications, healthcare, and financial services. This news hub provides investors and industry professionals with essential updates on the company's strategic initiatives, technological advancements, and market positioning.
Access timely updates including earnings announcements, partnership developments, and innovation milestones related to IBEX's digital CX platforms. Our curated news collection covers critical areas such as omni-channel customer experience enhancements, AI-driven analytics implementations, and global service delivery expansions.
Key content categories include financial performance reports, technology deployments like the ibex Wave iX suite, strategic client acquisitions, and operational updates across the company's global delivery centers. Each update is selected for its relevance to understanding IBEX's role in shaping modern customer experience ecosystems.
Bookmark this page for streamlined access to verified corporate communications and analysis-neutral reporting on IBEX's progress in digital transformation and BPO innovation. Regular updates ensure stakeholders maintain informed perspectives on the company's evolving service offerings and industry leadership.
IBEX Limited reported a strong first quarter for fiscal year 2023, with a revenue increase of 17.8% to $127.9 million year-over-year. Revenue from BPO 2.0 clients surged 44.3%, making up 76% of total revenue. Net income rose to $4.3 million with a margin of 3.4%, while non-GAAP adjusted EBITDA jumped 59.1% to $18.2 million. Additionally, fully diluted EPS climbed to $0.23. IBEX reaffirmed its fiscal year 2023 guidance, projecting organic revenue of $545 million to $555 million.
ImmunityBio announced positive results from the QUILT 3.032 trial involving N-803 combined with BCG for treating non-muscle invasive bladder cancer (NMIBC). The trial achieved a 71% complete response (CR) rate in carcinoma in situ (CIS) patients, with a median duration of response at 26.6 months. The FDA is reviewing the Biologics License Application (BLA) for this combination, with a decision expected on May 23, 2023. The treatment demonstrated significant efficacy, with a 90% probability of avoiding cystectomy at 24 months.
ibex (NASDAQ: IBEX), a global leader in business process outsourcing, announced its sponsorship of HLTH 2022 in Las Vegas from November 13-16, 2022. The company will showcase its award-winning technology aimed at enhancing customer experience in healthcare. Dan Hess, Senior VP at ibex, emphasized that today's healthcare consumers seek seamless digital experiences. The ibex Health CX solution integrates multiple communication channels to improve patient engagement. With a global presence of 34 operations and a workforce of over 30,000, ibex drives significant customer revenue, exceeding $2.2B annually.
IBEX Limited (Nasdaq: IBEX) announced it will release its first quarter 2023 financial results on November 15, 2022, after market close. Management will host a conference call at 4:30 p.m. ET to discuss financial results and business outlook. IBEX is a provider of business process outsourcing and customer engagement solutions, operating globally with 34 facilities and over 30,000 employees, managing nearly 200 million customer interactions annually.
ibex (NASDAQ: IBEX) has been awarded the 2022 Contact Center Technology Award by CUSTOMER Magazine for its innovative customer service technology, Wave X. This recognition highlights ibex's commitment to enhancing customer experiences through its advanced platform that integrates seamlessly with client tools. The award emphasizes Wave X's role in improving customer interactions, insights, and overall contact center performance, positioning ibex as a leader in customer engagement technology.
ibex (NASDAQ: IBEX) announced its sponsorship of Money 20/20 USA, a leading fintech conference, which will occur from October 23-26 in Las Vegas. Julie Casteel, Chief Strategic Accounts Officer and CMO, is set to speak at the event alongside industry leaders from PayPal and Klarna. Casteel emphasized the importance of data-driven customer experiences in a challenging market, highlighting ibex's role in creating digital-first solutions that enhance customer engagement while reducing costs. The company manages nearly 200 million customer interactions, generating over $2.2 billion in annual revenue.
ibex (NASDAQ: IBEX) is sponsoring the Customer Response Summit (CRS) in Coronado, CA, from October 24-26, 2022. The company will also host an exclusive dinner for customer experience (CX) leaders on October 24. This event aims to foster best practices in CX during challenging economic times. With over 30,000 employees and advanced technology like the Wave X platform, ibex is positioned to enhance customer interactions and reduce operational costs while driving significant revenue growth of over $2.2 billion annually.
FAQ
What is the current stock price of Ibex (IBEX)?
What is the market cap of Ibex (IBEX)?
